Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Mol Neurobiol. 2015 Sep 3;53(7):4809–4820. doi: 10.1007/s12035-015-9385-x

Fig. 7.

Fig. 7

Identification of the active compound of Rhizoma drynariae extract in the blood of rats subjected to CCI. The Waters Acquity UPLC was used to analyze R. drynariae extract and the active compound in the blood of CCI rats. a R. drynariae decoction chromatography. Retention times of peaks 1, 2, 3, and 4 were 8.698, 9.023, 6.597, and 3.987 min, respectively. b Chromatographic peak in the plasma of rats treated with R. drynariae. The retention time of peak 1 was 8.570 min. c Chromatographic peaks generated from the standards. Peaks 1–4 are eriodictyol, trans-cinnamic acid, naringin, and P-coumaric acid, and their retention times were 8.101, 9.011, 6.050, and 3.682 min, respectively